Management review is next week. ISO 13485 5.6 requires external signal data as input. Your team hasn't gathered it yet.

Here's what's happening right now: 391 new FDA recalls were posted this week, with 5 new Health Canada recalls. The dialysis convenience kit category shows multiple signals, including Medline's ADD A CATH DIALYSIS KIT and Centurion's CENTRAL LINE INSERTION TRAY, both citing silicone seal failures that could occlude fluid paths. Meanwhile, Edermy LLC's PIE PAK and PIE Trolley System recalls highlight 510(k) clearance issues, and orthopedic implants from Enovis face labeling errors.

For your board reporting and risk exposure quantification, this data reveals two critical patterns. First, component failures in kits (like seals) are driving patient safety risks in dialysis, requiring immediate supplier control reviews under 21 CFR 820. Second, regulatory non-compliance (lack of 510(k)s) and labeling errors persist as systemic issues, impacting competitive benchmarking and audit readiness. These signals should inform your management review, quantifying how similar product codes in your portfolio might face increased scrutiny.

We analyzed this across 548,000+ regulatory records and found that kit-related recalls often cluster around seal and connector failures, while clearance issues spike post-QMSR implementation. This pattern helps prioritize corrective actions and supplier audits.

See how your specific product codes compare at truemeddevice.com.